Rafael Fleites
Gastroenterology · Saint Cloud, FLNPI 1316974744
Payments from drug & device makers
Across 164 payments — averaging $14.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$398
- Nestle Healthcare Nutrition Inc.$352
- Bristol Myers Squibb$171
- Merck$54
- Takeda Pharmaceuticals U.S.A., Inc.$47
- plus $212 from 10 others
What the payments were for
- Food & beverage$2,348100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 73 | $1,113 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 30 | $398 |
| Nestle Healthcare Nutrition Inc. | 24 | $352 |
| Bristol Myers Squibb | 17 | $171 |
| Merck | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Vivus LLC | 3 | $44 |
| Daiichi Sankyo Inc. | 2 | $33 |
| Johnson & Johnson | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Evoke Pharma, Inc. | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Ardelyx, Inc. | 1 | $14 |
| Smith+Nephew | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $11 |
| Gilead | 1 | $11 |
How this compares
$2,348 in reported general payments places this provider in the 40th percentile of 1,388 gastroenterology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $4,026 |
| JanuviaSitagliptin Phosphate | 22 | $2,970 |
| MyrbetriqMirabegron | 14 | $1,616 |
| Levothyroxine Sodium | 85 | $1,278 |
| Atorvastatin Calcium | 63 | $843 |
| Duloxetine Hcl | 26 | $790 |
| Potassium Chloride | 40 | $535 |
| Losartan Potassium | 40 | $443 |
| Omeprazole | 26 | $405 |
| Tamsulosin Hcl | 32 | $321 |
| Metoprolol Succinate | 24 | $298 |
| Sertraline Hcl | 31 | $278 |
| Amlodipine Besylate | 17 | $231 |
| Gabapentin | 17 | $217 |
| MethotrexateMethotrexate Sodium | 11 | $202 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $54 | $2,97022 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Saint Cloud
- Howard SchwartzTavernier$38.8M
- Guy NeffSarasota$17.6M
- Syed LateefClermont$6.4M
- Jeffrey SchneiderCoral Springs$6M
- Zaid RanaMiami$5.4M
- David NelsonGainesville$5.2M
- Alan WeintraubTampa$4.7M
- Curtis FreedlandNew Port Richey$4.5M
- Paul HellsternCrystal River$4.5M
- Henry LevineOrlando$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.